Literature DB >> 26338822

Cyclophotocoagulation and cyclocryocoagulation as primary surgical procedures for open-angle glaucoma.

Isabel Gorsler1, Hagen Thieme1, Christian Meltendorf2.   

Abstract

PURPOSE: Comparative study of cyclophotocoagulation (CPC) and cyclocryocoagulation (CCT) as primary surgical procedures in patients with open-angle glaucoma with regard to efficacy and complications.
METHODS: In this retrospective cohort study, 184 eyes of 112 patients in whom cyclodestructive surgery was performed as a primary surgical procedure were examined. CPC was performed on 133 eyes and CCT on 51 eyes. A standardised multiple measurement of intraocular pressure (IOP) was performed on all patients preoperatively and at the follow-up examination after an average of 5.5 (1.5-12) months. In addition, the best-corrected visual acuity and the number of antiglaucoma agents were recorded.
RESULTS: On average, a reduction in IOP was observed after both of the cyclodestructive procedures (CPC: -1.55 ± 2.50 mmHg, p < 0.05; CCT: -2.33 ± 3.06 mmHg; p < 0.05). The average difference in IOP reduction between the two procedures (0.78 mmHg) proved to be statistically insignificant (p = 0.08). In contrast, greater patient age and higher preoperative IOP values were found to be highly significant influencing factors. In 45 % and 70 % of the patients treated with CPC and CCT, respectively, IOP was reduced by at least 20 %, with no increase in medication or with a reduction in medication of at least one substance with no increase in pressure. CPC and CCT produced an average loss of visual acuity of more than two lines in 10.5 % and 9.8 % of cases, respectively. Permanent hypotension did not occur in any of the cases.
CONCLUSIONS: A moderate reduction in IOP is achievable with both procedures, with CCT tending to produce a greater reduction in pressure. The efficacy of primary cyclodestructive procedures increases with increasing patient age and with higher preoperative IOP values. The risk of serious complications can be considered low.

Entities:  

Keywords:  Cyclocryotherapy; Cyclophotocoagulation; Primary open-angle glaucoma; Primary treatment

Mesh:

Year:  2015        PMID: 26338822     DOI: 10.1007/s00417-015-3159-z

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  25 in total

1.  Diode laser transscleral cyclophotocoagulation as a primary surgical treatment for primary open-angle glaucoma.

Authors:  P R Egbert; S Fiadoyor; D L Budenz; P Dadzie; S Byrd
Journal:  Arch Ophthalmol       Date:  2001-03

2.  Efficacy and safety of contact transscleral diode laser cyclophotocoagulation for advanced glaucoma.

Authors:  T Schlote; M Derse; K Rassmann; T Nicaeus; K Dietz; H J Thiel
Journal:  J Glaucoma       Date:  2001-08       Impact factor: 2.503

3.  Long-term outcome of initial ciliary ablation with contact diode laser transscleral cyclophotocoagulation for severe glaucoma. The Diode Laser Ciliary Ablation Study Group.

Authors:  O Kosoko; D E Gaasterland; I P Pollack; C L Enger
Journal:  Ophthalmology       Date:  1996-08       Impact factor: 12.079

4.  "Cyclodiode": results of a standard protocol.

Authors:  A F Spencer; S A Vernon
Journal:  Br J Ophthalmol       Date:  1999-03       Impact factor: 4.638

5.  [Transscleral cyclophotocoagulation as primary surgical intervention in glaucoma].

Authors:  N F K Winkler; J Funk
Journal:  Klin Monbl Augenheilkd       Date:  2013-04-29       Impact factor: 0.700

6.  Diode laser contact transscleral cyclophotocoagulation for refractory glaucoma in Asian patients.

Authors:  E Y Wong; P T Chew; C K Chee; J S Wong
Journal:  Am J Ophthalmol       Date:  1997-12       Impact factor: 5.258

Review 7.  Cyclodestructive procedures. I. Clinical and morphological aspects: a review.

Authors:  Franz Fankhauser; Sylwia Kwasniewska; Eugen Van der Zypen
Journal:  Ophthalmologica       Date:  2004 Mar-Apr       Impact factor: 3.250

8.  Cyclocryotherapy as an alternative treatment for primary glaucoma.

Authors:  R Hennekes; G Belgrado
Journal:  Bull Soc Belge Ophtalmol       Date:  1992

9.  Visual loss after transscleral diode laser cyclophotocoagulation for primary open-angle and neovascular glaucoma.

Authors:  Russell Pokroy; Yoel Greenwald; Ayala Pollack; Amir Bukelman; Miriam Zalish
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2008 Jan-Feb

10.  Contact transscleral cyclophotocoagulation with diode laser in refractory glaucoma.

Authors:  R Brancato; R G Carassa; P Bettin; M Fiori; G Trabucchi
Journal:  Eur J Ophthalmol       Date:  1995 Jan-Mar       Impact factor: 1.922

View more
  4 in total

1.  Freeze-thaw decellularization of the trabecular meshwork in an ex vivo eye perfusion model.

Authors:  Yalong Dang; Susannah Waxman; Chao Wang; Adrianna Jensen; Ralitsa T Loewen; Richard A Bilonick; Nils A Loewen
Journal:  PeerJ       Date:  2017-08-14       Impact factor: 2.984

Review 2.  Cyclodestructive Procedures in Glaucoma: A Review of Current and Emerging Options.

Authors:  Anna I Dastiridou; Andreas Katsanos; Philippe Denis; Brian A Francis; Dimitrios G Mikropoulos; Miguel A Teus; Anastasios-Georgios Konstas
Journal:  Adv Ther       Date:  2018-11-17       Impact factor: 3.845

3.  Effectiveness and Safety of Long Duration versus Short Duration Diode Laser Transscleral Cyclophotocoagulation.

Authors:  Jonathan Cheuk-Hung Chan; Shing Chuen Chow; Jimmy Shiu-Ming Lai
Journal:  Clin Ophthalmol       Date:  2020-01-22

4.  A Comparative Study between Ultrasound Cycloplasty and Cyclocryotherapy for the Treatment of Neovascular Glaucoma.

Authors:  Wang Ruixue; Wang Tao; Li Ning
Journal:  J Ophthalmol       Date:  2020-01-22       Impact factor: 1.909

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.